Forbion Ventures
Tracked across 2 events · 12 articles · First seen Jul 08, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Forbion Ventures participated in the private placement and will have board representation in the combined company.
Aug 17, 2026 · 6 articles
Business
Impact: Patrick Vink is a senior advisor to Forbion Ventures.
Jul 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Forbion Ventures live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard